The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...
Authors of a new study determined whether there is an association between age at puberty onset and the risk for multiple sclerosis as well as the effect of BMI on that relationship.
It has been thought that the risk of postpartum relapses in multiple sclerosis is high. However, researchers of a study that will be presented at the AAN Annual Meeting determined whether the scientific...
In hopes of improving disease monitoring and treatment, researchers of a study presented at the ACTRIMS Forum evaluated vascular contributions to multiple sclerosis pathology.
As both the prevalence of obesity and the number of MS cases increases, researchers say it is important to examine the relationship between obesity in children and adolescents and the later occurrence of...
Patients with multiple sclerosis who experience disease breakthrough often switch disease-modifying therapy, so researchers compared the efficacy of highly effective DMT with moderately effective DMT,...
Patients with multiple sclerosis who experience disease breakthrough often switch disease-modifying therapy, so researchers compared the efficacy of highly effective DMT with moderately effective DMT,...
